Alimera Sciences Inc. (ALIM)
NASDAQ: ALIM
· Real-Time Price · USD
5.54
-0.01 (-0.18%)
At close: Sep 13, 2024, 10:00 PM
Alimera Sciences Revenue Breakdown
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| International Segment Revenue | 9.44M | 8.46M | 7.12M | 5.3M | 5.66M | 5.96M | 4.61M | 4.68M | 5.66M | 4.98M | 5.57M | 5.24M | 15.92M | 5.57M | 6.41M | 5.51M | 6.62M | 7.47M | 7.84M | 4.16M | 3.54M | 6.12M | 6.25M | 2.65M | 2.92M | 2.83M | 2.64M | 2.64M | 2.31M | 2.17M | 2.42M | 2.11M | 2.35M | 1.68M | 3.43M | 1.87M | 1.97M |
| International Segment Revenue Growth | +11.62% | +18.86% | +34.28% | -6.39% | -5.06% | +29.37% | -1.45% | -17.36% | +13.70% | -10.63% | +6.40% | -67.10% | +185.90% | -13.21% | +16.39% | -16.73% | -11.37% | -4.79% | +88.62% | +17.62% | -42.28% | -1.94% | +136.11% | -9.36% | +3.29% | +7.01% | -0.04% | +14.23% | +6.40% | -10.32% | +14.62% | -10.00% | +39.66% | -50.92% | +83.36% | -5.22% | n/a |
| United States Segment Revenue | 17.56M | 14.55M | 19.19M | 18.06M | 11.88M | 7.58M | 9.42M | 8.92M | 8.94M | 6.92M | 8.39M | 6.92M | 5.79M | 5.65M | 7.36M | 6.96M | 3.42M | 7.07M | 9.51M | 8.69M | 7.32M | 6.77M | 8.87M | 8.49M | 8M | 6.98M | 6.5M | 7.14M | 8.06M | 4.45M | 8.25M | 6.18M | 7.21M | 4.12M | 6.33M | 5.03M | 3.8M |
| United States Segment Revenue Growth | +20.66% | -24.16% | +6.23% | +52.11% | +56.63% | -19.50% | +5.59% | -0.26% | +29.25% | -17.51% | +21.27% | +19.53% | +2.48% | -23.27% | +5.72% | +103.57% | -51.61% | -25.64% | +9.35% | +18.74% | +8.19% | -23.71% | +4.44% | +6.16% | +14.65% | +7.31% | -8.97% | -11.33% | +81.24% | -46.15% | +33.47% | -14.21% | +74.99% | -34.97% | +25.87% | +32.28% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 15.88M | 14.51M | 14.15M | 11.55M | 10.81M | 9.97M | 9.1M | 9.86M | 9.81M | 10.09M | 10.37M | 8.56M | 8.69M | 8.23M | 8.44M | 7.38M | 7.36M | 8.85M | 10.31M | 9.56M | 9.78M | 9.31M | 10.14M | 8.93M | 9.15M | 9.82M | 10.09M | 9.32M | 8.07M | 8.77M | 11.54M | 11.1M | 11.55M | 10.5M | 10.81M | 9.98M | 10.75M | 10.75M |
| Selling, General, and Administrative Revenue Growth | +9.38% | +2.59% | +22.52% | +6.85% | +8.34% | +9.63% | -7.68% | +0.47% | -2.80% | -2.63% | +21.11% | -1.47% | +5.54% | -2.51% | +14.36% | +0.35% | -16.90% | -14.14% | +7.88% | -2.30% | +5.13% | -8.20% | +13.57% | -2.50% | -6.81% | -2.63% | +8.23% | +15.49% | -7.92% | -24.06% | +4.03% | -3.91% | +9.95% | -2.79% | +8.28% | -7.13% | -0.02% | n/a |
| Research and Development Revenue | 4.26M | 4.36M | 4.77M | 4.04M | 3.65M | 4.16M | 4.23M | 4.48M | 3.93M | 3.58M | 3.72M | 3.28M | 3.57M | 3.21M | 2.51M | 2.47M | 1.81M | 2.88M | 2.67M | 2.76M | 2.83M | 2.73M | 2.88M | 2.8M | 2.78M | 2.82M | 3.08M | 3.3M | 2.24M | 2.11M | 2.89M | 3.26M | 3.21M | 3.02M | 3.62M | 4.08M | 3.81M | 3.33M |
| Research and Development Revenue Growth | -2.25% | -8.56% | +17.90% | +10.88% | -12.39% | -1.56% | -5.64% | +14.01% | +9.74% | -3.68% | +13.48% | -8.10% | +11.02% | +28.21% | +1.50% | +36.41% | -37.22% | +7.98% | -3.30% | -2.58% | +3.92% | -5.18% | +2.75% | +0.79% | -1.59% | -8.26% | -6.76% | +47.41% | +6.07% | -26.96% | -11.41% | +1.75% | +6.13% | -16.53% | -11.28% | +6.89% | +14.60% | n/a |
| Sales and Marketing Revenue | 8.51M | 9.08M | 7.77M | 7.94M | 6.43M | 5.8M | 5.76M | 6.5M | 6.87M | 6.85M | 7.17M | 5.75M | 5.33M | 4.82M | 4.99M | 4.76M | 4.38M | 5.67M | 6.55M | 6.44M | 6.11M | 5.91M | 6.14M | 5.48M | 5.93M | 5.97M | 6.65M | 6M | 5.06M | 5.5M | 7.36M | 7.45M | 7.51M | 7.11M | 7.09M | 6.95M | 6.92M | 7.13M |
| Sales and Marketing Revenue Growth | -6.29% | +16.92% | -2.17% | +23.41% | +10.85% | +0.68% | -11.36% | -5.26% | +0.18% | -4.41% | +24.66% | +7.88% | +10.65% | -3.35% | +4.64% | +8.72% | -22.74% | -13.35% | +1.69% | +5.39% | +3.30% | -3.73% | +12.08% | -7.53% | -0.72% | -10.19% | +10.73% | +18.62% | -8.03% | -25.24% | -1.23% | -0.77% | +5.64% | +0.31% | +1.99% | +0.35% | -2.86% | n/a |